Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography

Similar documents
New 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA

PISA Evaluation of Mitral Regurgitation. Raymond Graber, MD Cardiac Anesthesia Group University Hospitals Case Medical Center 4/07/2011

MITRAL REGURGITATION ECHO PARAMETERS TOOL

True morphology of mitral regurgitant flow assessed by three- dimensional transesophageal echocardiography

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

How to assess ischaemic MR?

What are the best diagnostic tools to quantify aortic regurgitation?

ECHOCARDIOGRAPHY DATA REPORT FORM

Quantification of MR

Disclosures Rebecca T. Hahn, MD, FASE

8/31/2016. Mitraclip in Matthew Johnson, MD

EVALUATION OF CHRONIC MITRAL REGURGITATION: ASSESSING MECHANISMS AND QUANTIFYING SEVERITY 2018 STRUCTURAL HEART DISEASE CONFERENCE June 1, 2018

Professors Carpentier and McGoon Mechanism, resulting from the disease Severity of regurgitation, resulting from the mechanism Echo

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

aortic regurgitation, vena contracta area, vena contracta width, live three-dimensional echocardiography

Analysis of Procedural Effects of Percutaneous Edge-to-Edge Mitral Valve Repair by 2D and 3D Echocardiography

Quantifying Aortic Regurgitation

Quantification of Mitral Stenosis: Planimetry, pressure Half time, Continuity Common Errors

Functional Mitral Regurgitation

CHAPTER 4 AN EFFICACIOUS APPROACH FOR THE QUANTIFICATION OF MITRAL REGURGITATION USING IMAGE PROCESSING AND PROXIMAL FLOW CONVERGENCE METHOD

Reproducibility of Proximal Isovelocity Surface Area, Vena Contracta, and Regurgitant Jet Area for Assessment of Mitral Regurgitation Severity

Marti McCulloch, BS, MBA, RDCS, FASE Houston, Texas

Primary Mitral Regurgitation

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Mitral regurgitation (MR) is a

Milind Desai Christine Jellis Teerapat Yingchoncharoen Editors. An Atlas of Mitral Valve Imaging

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

Cover Page. The handle holds various files of this Leiden University dissertation.

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?

Revealing new insights. irotate electronic rotation and xplane adjustable biplane imaging. Ultrasound cardiology. irotate and xplane

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

Case Reviews: Hemodynamic Calculations in Valvular Regurgitation

The Doppler Examination. Katie Twomley, MD Wake Forest Baptist Health - Lexington

Introduction RECOMMENDATIONS

Asymptomatic Valvular Disease:

Guidelines in perspective?

ΔΙΑΔΕΡΜΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΟΜΙΚΩΝ ΠΑΘΗΣΕΩΝ: Ο ΡΟΛΟΣ ΤΗΣ ΑΠΕΙΚΟΝΙΣΗΣ ΣΤΟ ΑΙΜΟΔΥΝΑΜΙΚΟ ΕΡΓΑΣΤΗΡΙΟ ΣΤΗΝ ΤΟΠΟΘΕΤΗΣΗ MITRACLIP

School, The University of Texas Health Science Center at Houston, TX.

Improvements in outcomes for heart valve surgery, in particular mitral valve repair, have dictated

Use of MitraClip Beyond Everest Criteria

LUST trial. Echocardiography USER S MANUAL

Titel Kardiologie-SG.ch hot topics in heart failure and mitral regurgitation

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies

Three-dimensional echocardiography in the clinical world

Echocardiographic evaluation of mitral stenosis

MR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras

Transthoracic Echocardiographic

ICE: Echo Core Lab-CRF

Real-Time 3D: Theory, Knobology and Data Acquisition

Index. B B-type natriuretic peptide (BNP), 76

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Chapter 20. JACC Cardiovasc Imaging 2009;2:

When should we intervene surgically in pediatric patient with MR?

CLIP ΜΙΤΡΟΕΙ ΟΥΣ: ΠΟΥ ΒΡΙΣΚΟΜΑΣΤΕ;

CHAPTER 5 EFFICIENT APPROACHES FOR QUANTIFICATION OF AORTIC REGURGITATION USING PROXIMAL ISOVELOCITY SURFACE AREA PROCESS

Exercise-Induced Changes in Degenerative Mitral Regurgitation

Role of real-time three-dimensional transesophageal echocardiography in mitral valve repair

Quantitative Assessment of Mitral Regurgitation

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

AATS Annual Meeting Seattle, WA Irving Kron, M.D. Professor and Chairman Department of Surgery University of Virginia Hospital Charlottesville,

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

Organic mitral regurgitation

Prosthetic valve dysfunction: stenosis or regurgitation

The Edge-to-Edge Technique f For Barlow's Disease

Mitral Valve Repair for Functional Mitral Regurgitation- Description of A New Technique and Classification System

BrijM ainim D,FA CC ClinicalP rofessorofm edicine. FloridaAtlanticU niversity,bocar aton,fl. R egionalm edicaldirectoroft ranscathetert herapies

Quantification of Aortic Regurgitation

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

Uncommon Doppler Echocardiographic Findings of Severe Pulmonic Insufficiency

PROSTHETIC VALVE BOARD REVIEW

NEW GUIDELINES. A Guideline Protocol for the Assessment of Aortic Regurgitation From the British Society of Echocardiography Education Committee

ASCeXAM / ReASCE. Practice Board Exam Questions Monday Morning

What echo measurements are key prior to MitraClip?

Comprehensive Echo Assessment of Aortic Stenosis

Cover Page. The handle holds various files of this Leiden University dissertation.

Quantitative Assessment of Mitral Regurgitation

Advanced Evaluation of Left Ventricular Function in Degenerative MR. Dr Julien Magne, PhD University of Liege, CHU Sart Tilman, Liege, Belgium

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA

The diagnosis of mitral regurgitation (MR) caused

Acute Effects of Cardiac Resynchronization Therapy on Functional Mitral Regurgitation in Advanced Systolic Heart Failure

Secondary MR joint with the mitral academy. What is new in our understanding of this disease? Luc Pierard University Hospital, Liège

MitraClip in the ICCU: Which Patient will Benefit?

Quantification of Functional Mitral Regurgitation by Real-Time 3D Echocardiography

The difficult patient with mitral regurgitation

G. AORTIC STENOSIS (AS)

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

Assessing Function by Echocardiography in VHD Asymptomatic Severe Organic MR. Dr. Julien Magne, PhD Sart Tilman Liège, BELGIUM

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

CAS SECTION 3 PASSPORT

M-Mode Echocardiography Is it still Alive? Itzhak Kronzon, MD,FASE. Sampling Rate M-Mode: 1800 / sec 2D: 30 / sec

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation

Comparison of Vena Contracta Width by Multiplane Transesophageal Echocardiography With Quantitative Doppler Assessment of Mitral Regurgitation

Part II: Fundamentals of 3D Echocardiography: Acquisition and Application

Insuffisance mitrale

Transcription:

Direct Planimetry of Mitral Valve Regurgitation Orifice Area by Real-time 3D Transesophageal Echocardiography Ertunc Altiok, Sandra Hamada, Silke van Hall, Mehtap Hanenberg, Eva Grabskaya, Michael Becker, Nikolaus Marx, Rainer Hoffmann University Hospital Aachen, Germany ESC 2010

Conflict of Interest - Disclosure Within the past 12 months, I have had a financial interest/arrangement or affiliation with the organization(s) listed below. Affiliation/Financial Relationship Company 1. Honoraria for lectures no 2. Honoraria for advisory board activities no 3. Participation in clinical trials no 4. Research funding no

Background Quantification of mitral valve regurgitation (MR) including calculation of the effective regurgitant orifice area (EROA) is performed using proximal isovelocity surface area (PISA) method. However, quantification by this method may be limited in eccentric regurgitation or non-circular regurgitant orifice area. Enriquez-Sarano, JACC 1995

Aim To compare measurements of direct planimetry of anatomic regurgitant orifice area (AROA) by 3D TEE with effective regurgitant orifice area (EROA) by the PISA method.

Patients and Echocardiography System 72 consecutive patients (mean age 71 ± 13 years) with significant mitral valve regurgitation (EROA>0.1 cm 2 by PISA method). Echocardiographic system (ie 33, Philips Medical Systems, Andover, MA, USA) with a matrix-array TEE probe (X7-2t).

Quantitative Methods to Define Mitral Regurgitation Severity EROA by PISA method: Effective regurgitant orifice area (EROA) was determined by PISA method with conventional 2D color Doppler TEE. AROA by 3D TEE planimetry: Anatomic mitral valve regurgitant orifice area (AROA) was measured directly with commercially available Software (3DQ, QLAB- Version 7.0, Philips Medical Systems).

Patient Characteristics N=72 Age, years 70.6±13.3 Male/ female 37/35 NYHA* class I, n (%) II, n (%) III, n (%) IV, n (%) 9 (13) 26 (36) 28 (38) 9 (13) Ejection fraction, % 48.9±13.6 4-chamber left atrial area, cm 2 25.0±5.8 4-chamber color Doppler jet area, cm 2 7.4±3.4 Etiology of mitral regurgitation Ischemic heart disease / dilated cardiomyopathy, n (%) Mitral valve prolapse / flail leaflet, n (%) Rheumatic heart disease / others, n (%) 22 (30) 25 (35) 25 (35) Regurgitant volume by convergence method, ml 48.2±32.8

EROA by PISA Method 2 π r 2 x V aliasing / PeakV Reg = EROA 2 π x 1,0 cm 2 x 35.6 cm/s / 580 cm/s = 0.39 cm 2 LVOT view Intercommissural view r=1,0cm

Mitral Valve by 3D TEE with Zoom Mode View from left ventricle View from left atrium

Analysis of 3D TEE Volume by Quantification Software (QLAB, Philips)

Visualization of Mitral Valve Regurgitant Orifice in Mid- to Endsystole after Adjusting Cut Planes

Planimetry of Anatomic Regurgitant Orifice Area by 3D TEE with Zoom Mode AROA planimetry of anatomic regurgitant orifice area (0.43 cm 2 ) AROA d1 d2 Ratio d1/d2 = 4.03 (non-circular) d1 distance medial-lateral (1.49 cm) d2 distance anteriorposterior (0.37 cm)

Difference of AROA s Intraobserver and Interobserver Variability of Re-Measurements of AROA by 3D TEE (n=26) Intraobserver Interobserver Difference of AROA s 0,2 0,2 0,1 +1.96 SD 0,10 0,1 +1.96 SD 0,12 0,0 Mean 0,01 0,0 Mean 0,02-0,1-1.96 SD -0,08-0,1-1.96 SD -0,08-0,2 0,0 0,2 0,4 0,6 0,8 1,0 AVERAGE of AROA (cm ²) -0,2 0,0 0,2 0,4 0,6 0,8 1,0 AVERAGE of AROA (cm²)

Results EROA by PISA method vs. direct planimetry of anatomic mitral valve regurgitant orifice area (AROA) EROA (by 2D TEE PISA method) AROA (by 3D TEE direct planimetry) All patients (n=72) Circular AROA (n=14) Non-circular AROA (n=58) 0.30±0.20 cm² 0.30±0.20 cm² 0.33±0.25 cm² 0.32±0.24 cm² 0.30±0.19 cm² 0.29±0.20 cm²

EROA (cm²) Difference EROA - AROA (cm²) EROA by PISA Method vs. Direct Planimetry of Anatomic Mitral Valve Regurgitant Orifice Area (AROA) All patients (n=72) 1,2 1,0 0,8 0,6 0,4 0,2 r=0.96 SEE= 0.058 cm² 0,4 0,3 0,2 0,1 0,0-0,1-0,2-0,3 +1.96 SD 0,12 Mean 0,01-1.96 SD -0,11 0,0 0,0 0,2 0,4 0,6 0,8 1,0 1,2 AROA (cm²) -0,4 0,0 0,2 0,4 0,6 0,8 1,0 1,2 AVERAGE of EROA and AROA (cm²)

EROA (cm²) EROA (cm²) Non-Circular vs. Circular Regurgitation Orifice Area Non-Circular AROA (n=58) Circular AROA (n=14) 1,2 1,0 r=0.95 SEE= 0.061 0.061 cm² cm² 1,2 1,0 r=0.99 SEE= 0.036 cm² 0,8 0,8 0,6 0,6 0,4 0,4 0,2 0,2 0,0 0,0 0,2 0,4 0,6 0,8 1,0 1,2 AROA (cm²) 0,0 0,0 0,2 0,4 0,6 0,8 1,0 1,2 AROA (cm²)

EROA (cm²) EROA (cm²) Comparison between Groups with EROA <0.2 cm² and EROA 0.2 cm² EROA < 0.2 cm² (n=30) EROA 0.2 cm² (n=42) 0,3 r=0.60 SEE= 0.021 cm² (n=30) 1,2 1,0 r=0.95 SEE= 0.063 cm² (n=42) 0,2 0,8 0,6 0,1 0,4 0,2 0,0 0,0 0,1 0,2 0,3 AROA (cm²) 0,0 0,0 0,2 0,4 0,6 0,8 1,0 1,2 AROA (cm²)

Limitations Limited frame rate of RT 3D TEE with Zoom Mode impairs MR quantification in rapidly changing regurgitant orifice areas. Very calcified valvular leaflets, severely distorted valvular apparatus as well as flail leaflets present difficulties for direct planimetry of the AROA. Quantification of MR due to perforation of a mitral leaflet or in case of multiple regurgitant orifices may be challenging.

Limitations Measurements by 3D TEE were compared with an echocardiography based technique (PISA method) and not with an independent method.

Conclusions Measurements of anatomic regurgitant orifice area by 3D TEE correlate well with the EROA by PISA method. Agreement between methods is better in patients with a circular mitral regurgitation orifice compared to patients showing a noncircular orifice.

Thank You.